Objective: The pathological picture in ischemic tissue injury shares features with the inflammatory response. Hypoxia-mediated induction of interleukin-6 (IL-6) could set in motion the mechanisms limiting inflammation in ischemia. Intrauterine growth restriction (IUGR) represents a human model of chronic fetal hypoxia. The purpose of this study was a first-time exploration to determine whether cord blood obtained at the delivery of small-for-gestational-age (SGA) infants has increased concentrations of inflammatory markers.
Introduction
The pathological picture in hypoxic-ischemic tissue injury shares features with the inflammatory response, including production of proinflammatory cytokines and acute-phase proteins. 1 Intrauterine growth restriction (IUGR) represents a human model of chronic fetal hypoxia, 2, 3 and a relation between IUGR and proinflammatory cytokines has been described before. 4 There are many markers of inflammation known to date. Among them, interleukin-6 (IL-6), tumor necrosis factor-a (TNF-a), C-reactive protein (CRP) and thrombopoietin (TPO) are readily available in our laboratory. IL-6 is secreted by T cells and macrophages and is an important mediator of fever and of the acute-phase response, 5 while TNF-a, produced mainly by macrophages, is also produced by many other cell types, including the placenta, and is also involved in the stimulation of the acute-phase reaction. 6, 7 Both IL-6 and TNF-a stimulate the hepatic acute-phase response, leading to an increase in CRP. 8 TPO has recently been shown to act as an acute-phase protein that correlates with IL-6 in many inflammatory disorders. 9 The purpose of this study was a first-time exploration to determine whether cord blood obtained at the delivery of small-forgestational-age (SGA) infants has increased concentrations of IL-6, TNF-a, TPO, and CRP.
Methods

Population
Cord blood samples were collected from 20 SGA (term and nearterm >35-week gestation) infants and from 20 appropriate-forgestational-age (AGA) controls. The infants were defined as SGA or AGA using our national curves previously published by one of the authors. 10 In order to obtain a relatively homogenous group of infants (in terms of the etiology of IUGR), we excluded infants who were exposed to maternal chronic diseases, smoking, diabetes, alcohol or drug use, and pregnancy-associated hypertension. We also excluded all infants with neonatal depression (both groups had to have an Apgar score X7 at 1 min and a normal cord pH (>7.25)). The patients were consecutive and the study was approved by our local ethics committee. Written informed consent forms were signed by both parents of the infants.
Laboratory methods
Cord blood was obtained from puncture of the umbilical vein in a double-clamped segment of the cord. Cord-serum cytokines and TPO were measured by enzyme linked immunosorbent assay (R&D Systems Europe Ltd, Abingdon, UK). CRP was measured using a turbidometric immunoassay by an automated analyzer (ADVIA 1650 Chemistry System, Bayer, Newbury, UK).
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Statistical analysis
The Minitab statistical program was used for analyses (Minitab, State College, PA, USA). Statistical analysis was done by Kruskal-Wallis test. Data are represented as mean ± 1 s.d. A P value <0.05 was considered significant.
Results
The clinical characteristics of the patients in both groups are presented in Table 1 . The patients were similar in terms of maternal age, parity, mode of analgesia (epidural or spinal in all cases), mode of delivery, race (all Jewish and White), gender and Apgar scores. The groups differed significantly in terms of gravidity, gestational age, birth weight and head circumference (Table 1) . SGA infants had a significantly smaller birth weight than AGA controls, with a smaller gestational age by 1 week (Table 1) . There were significant elevations in IL-6, CRP and TPO in the SGA compared with the AGA group (Table 2) , which persisted in multiple regression analysis even after taking into account the gestational age. The difference in TNF-a values between the SGA and control groups did not reach statistical significance in univariate analysis (P ¼ 0.087). However, in multiple regression analysis and after taking account the gestational age, the difference became significant (P ¼ 0.022).
Discussion
We have shown that infants who suffered from IUGR have elevated concentrations of cord serum IL-6, TNF-a, CRP and TPO.
These findings are highly suggestive of a state of inflammation in the IUGR fetus. Indeed, blood concentrations of IL-6, TNF-a and CRP are well-known markers of inflammation that are interrelated because, as pointed out in the introduction section, both IL-6 and TNF-a stimulate the hepatic acute-phase response, leading to an increase in CRP and a number of other mediators. 1, 2 TNF-a, also called cachexin, is a well-known cytokine involved in systemic inflammation in the stimulation of the acute phasereaction. 7 TNF-a is produced mainly by macrophages but is also produced by many other cell types, including the placenta. It has been implicated in the abnormally high levels of trophoblast apoptosis seen in placentae from pregnancies complicated by the delivery of SGA infants. The production of TNF-a stimulates the apoptosis of placental trophoblasts associated with pregnancies complicated by IUGR. 7 Similar to our findings, Trevisanuto et al. 12 showed that, in SGA infants, CRP concentrations are higher than those in AGA neonates, suggesting the presence of an inflammatory process in this group of patients during the fetal life.
TPO is a well-characterized hematopoietic factor that is thought to be the primary regulator of megakaryocytopoiesis and thrombopoiesis. It has recently been shown that in inflammatory disorders there are positive correlations between TPO and IL-6 and that TPO acts as an acute-phase protein. 9 This finding has to be weighed against the finding that IUGR is a risk factor for thrombocytopenia, as shown by others and us. 13, 14 Thus, from our findings, we suggest that IUGR involves chronic inflammation.
Anti-inflammatory cytokine levels were not evaluated in this study. However, there is strong evidence that they have a critical Abbreviations: AGA, appropriate-for-gestational-age; F, female; M, male; NS, nonsignificant; SGA, small-for-gestational-age.
Numbers are mean ± 1 s.d., or actual numbers. Median and range are also provided for Apgar scores. Abbreviations: AGA, appropriate-for-gestational-age; CRP, C-reactive protein; IL-6, interleukin-6; SGA, small-for-gestational-age; TNF-a, tumor necrosis factor-a; TPO, thrombopoietin.
Numbers are mean ± 1 s.d.
Increased cord serum inflammatory markers G Amarilyo et al role in pregnancy maintenance 15 and that the risk of the delivery of a SGA infant is associated with anti-inflammatory cytokine polymorphisms. 16 This may explain the report of increased interleukin-10 concentrations in the amniotic fluid in IUGR pregnancies. 17 IUGR creates an adverse intrauterine environment to the fetus, to the inclusion of relative oxygen deprivation. In support of this are several facts: (1) fetal hypoxia has been documented in IUGR fetuses by cordocentesis 18 ; (2) erythropoietin is elevated in newborn SGA infants (presumably in response to fetal hypoxia) 19 ; and (3) IUGR is a known risk factor for increased erythropoiesis, as evidenced by increased numbers of circulating nucleated red blood cells at birth 20 and increased rates of polycythemia. 21 Therefore, as hypoxia-ischemia is known to be capable of stimulating an inflammatory response, we speculate that relative ischemia in IUGR is responsible for the inflammatory picture that we here describe. The practical application of our finding belongs to the field of speculations. It is known that periventricular leukomalacia is more frequently observed in SGA infants. 22 We also know that inflammation (in particular caused by chorioamnionitis) is strongly associated with the development of periventricular leukomalacia. Thus, it is theoretically possible that antiinflammatory therapies will be developed in the future with the aim of preventing periventricular leukomalacia.
We conclude that significant increases were found in the cord blood concentrations of known inflammatory markers in SGA infants compared with controls.
